Loading stock data...
BioMarin Pharmaceutical Inc. (BMRN) Stock Price, Chart & Analysis
BioMarin Pharmaceutical Inc.BMRN
Market Closed$58.58
+$0.51+0.88%
BMRN Market Indicators
Very Bearish
Market Sentiment
Historical Price Chart
View the historical price chart for BMRN to analyze trends and spot opportunities. Use our interactive chart to compare past performance and make informed decisions.
BioMarin Pharmaceutical Inc. (BMRN)
Loading chart data...
Is BioMarin Pharmaceutical Inc. (BMRN) Stock a Buy in 2025?
YES
STRONG BUY
Score: 100/100
Yes, BMRN stock appears to be a good buy in 2025 based on our comprehensive analysis.
Comprehensive analysis of whether BMRN stock is a good investment in 2025, including growth drivers, valuation metrics, risk factors, and analyst recommendations.
Growth Drivers
- Strong revenue growth of 18.0%
- Strong profit margins of 21.5%
- Healthcare sector momentum
Valuation Considerations
- Analyst price targets suggest 66.6% upside potential
- Mid-large cap with growth potential
Risk Factors
- High debt-to-equity ratio of 10.02
- Healthcare sector cyclicality
Analyst Consensus
Buy Ratings:8
Hold Ratings:1
Sell Ratings:1
Avg. Price Target:$97.62
Upside Potential:66.6%
Investment Summary
BMRN presents a mixed investment profile for 2025. The company shows strong growth drivers including strong revenue growth of 18.0%, though analyst price targets suggest 66.6% upside potential.
Analyst sentiment is generally positive with 8 buy ratings vs 1 sell ratings.
Investors should weigh the growth potential against the identified risks, particularly high debt-to-equity ratio of 10.02, and consider their own risk tolerance and investment timeline.
Final Recommendation
STRONG BUY
Recommendation Score
Overall Score:100/100
Strong Buy
2030 Price Prediction
Predicted Price:$99.29
Potential Return:+69.5%
Key Factors
- Strong revenue growth
- Very strong analyst buy consensus
- Very significant upside potential
- Good long-term growth potential to 2030
- Extremely high debt levels
- Debt-to-Market-Cap Ratio: 5.4% (Very Low)
Investment Decision
Based on our comprehensive analysis of BMRN's financial metrics, growth prospects, valuation, analyst sentiment, and risk factors, we recommend a STRONG BUY. This recommendation considers the company's current fundamentals, market position, and future growth potential while accounting for identified risks and market conditions.
bmrn Stock Price Prediction 2030
Predicted 2030 Price
$99.29
+69.5%from current price
Based on revenue growth analysis and market trends, bmrn stock is projected to reach $99.29 by 2030, representing a 69.5% increase from the current price of $58.58.
Current Price
$58.58
Revenue Growth
15.9%
Analyst Target
$97.62
View Full Prediction Analysis
Get detailed analyst targets, key factors, and comprehensive forecast analysis
How to Invest in bmrn Stock?
Quick Investment Insights for bmrn
Low Volatility (Beta: 0.18)
1. Research Fundamentals
Analyze financial statements and market position
2. Technical Analysis
Review price charts and technical indicators
3. Risk Assessment
Evaluate market and company-specific risks
Company Profile
BioMarin Pharmaceutical Inc.
Healthcare
Biotechnology
BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Eur...
Employees
3,040
Market Cap
$11.25B